Davies KD[Author] - Search Results

Year	Number of Results
2007	2
2008	2
2009	1
2010	3
2011	3
2012	2
2013	3
2014	2
2015	2
2016	3
2017	5
2018	7
2019	11
2020	8
2021	5
2022	3
2023	3
2024	2

1

Skipping Expected Mechanisms of MET-Mediated Oncogenesis.

Davies KD, Merrick DT. Davies KD, et al. J Thorac Oncol. 2020 Jan;15(1):9-11. doi: 10.1016/j.jtho.2019.11.003. J Thorac Oncol. 2020. PMID: 31864551 Free article. No abstract available.

2

ERBB2 (HER2) Alterations in Colorectal Cancer.

Roy-Chowdhuri S, Davies KD, Ritterhouse LL, Snow AN. Roy-Chowdhuri S, et al. Among authors: davies kd. J Mol Diagn. 2022 Oct;24(10):1064-1066. doi: 10.1016/j.jmoldx.2022.07.001. Epub 2022 Aug 7. J Mol Diagn. 2022. PMID: 35944596 Free article. No abstract available.

3

Rearranging Detection of Gene Rearrangements.

Davies KD, Doebele RC, Aisner DL. Davies KD, et al. J Thorac Oncol. 2015 Aug;10(8):1129-30. doi: 10.1097/JTO.0000000000000603. J Thorac Oncol. 2015. PMID: 26200265 Free article. No abstract available.

4

Mutational Signatures in Cancer: Laboratory Considerations and Emerging Applications.

Dong F, Davies KD. Dong F, et al. Among authors: davies kd. J Mol Diagn. 2023 Aug 24:S1525-1578(23)00179-4. doi: 10.1016/j.jmoldx.2023.08.002. Online ahead of print. J Mol Diagn. 2023. PMID: 37633594 Review.

5

Evolution of acquired resistance in a ROS1⁺ KRAS G12C⁺ NSCLC through the MAPK pathway.

Priest K, Le A, Gebregzabheir A, Nijmeh H, Reis GB, Mandell M, Davies KD, Lawrence C, O'Donnell E, Doebele RC, Bao L, Aisner DL, Schenk EL. Priest K, et al. Among authors: davies kd. NPJ Precis Oncol. 2023 Jan 23;7(1):9. doi: 10.1038/s41698-023-00349-0. NPJ Precis Oncol. 2023. PMID: 36690705 Free PMC article.

6

Molecular pathways: ROS1 fusion proteins in cancer.

Davies KD, Doebele RC. Davies KD, et al. Clin Cancer Res. 2013 Aug 1;19(15):4040-5. doi: 10.1158/1078-0432.CCR-12-2851. Epub 2013 May 29. Clin Cancer Res. 2013. PMID: 23719267 Free PMC article. Review.

7

Molecular Pathology Education: An Association for Molecular Pathology Webinar Series on Emerging and Evolving Biomarkers Structured for Specific Audiences.

Barker LP, Ritterhouse LL, Snow AN, Davies KD. Barker LP, et al. Among authors: davies kd. J Mol Diagn. 2022 Feb;24(2):105-106. doi: 10.1016/j.jmoldx.2021.11.003. Epub 2021 Nov 24. J Mol Diagn. 2022. PMID: 34838775 Free article. No abstract available.

8

Targetable molecular alterations in congenital glioblastoma.

Gilani A, Donson A, Davies KD, Whiteway SL, Lake J, DeSisto J, Hoffman L, Foreman NK, Kleinschmidt-DeMasters BK, Green AL. Gilani A, et al. Among authors: davies kd. J Neurooncol. 2020 Jan;146(2):247-252. doi: 10.1007/s11060-019-03377-8. Epub 2019 Dec 24. J Neurooncol. 2020. PMID: 31875306

9

MET Exon 14 Skipping Mutations in Non-Small-Cell Lung Cancer: An Overview of Biology, Clinical Outcomes, and Testing Considerations.

Socinski MA, Pennell NA, Davies KD. Socinski MA, et al. Among authors: davies kd. JCO Precis Oncol. 2021 Apr 13;5:PO.20.00516. doi: 10.1200/PO.20.00516. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34036238 Free PMC article. Review. No abstract available.

10

The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.

Graham DK, DeRyckere D, Davies KD, Earp HS. Graham DK, et al. Among authors: davies kd. Nat Rev Cancer. 2014 Dec;14(12):769-85. doi: 10.1038/nrc3847. Nat Rev Cancer. 2014. PMID: 25568918 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year